Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125548951 | 12554895 | 1 | I | 20160628 | 20160713 | 20160713 | EXP | JP-JNJFOC-20160627527 | JOHNSON AND JOHNSON | ABE J, UMETSU R, MATAKI K, KATO Y, UEDA N, NAKAYAMA Y, ET AL. ANALYSIS OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS USING THE JAPANESE ADVERSE DRUG EVENT REPORT DATABASE. JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES 2016;2:14:1-10. | 0.00 | Y | 0.00000 | 20160713 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125548951 | 12554895 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED | ||||||||
| 125548951 | 12554895 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125548951 | 12554895 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125548951 | 12554895 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125548951 | 12554895 | Stevens-Johnson syndrome | |
| 125548951 | 12554895 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |